Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma

BACKGROUND: Immunohistochemical detection of prostate specific antigen (PSA) is widely used to identify metastatic prostatic adenocarcinoma. However, PSA may not be expressed in some poorly differentiated prostatic carcinomas and its immunoreactivity has been found in some non-prostatic tissues. P50...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Ming, Dhir, Rajiv, Parwani, Anil V
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174437/
https://www.ncbi.nlm.nih.gov/pubmed/17963516
http://dx.doi.org/10.1186/1746-1596-2-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2174437/
https://www.ncbi.nlm.nih.gov/pubmed/17963516
http://dx.doi.org/10.1186/1746-1596-2-41

Ejemplares similares